How we think about protecting data
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Jul-2025 17:11 ET (30-Jul-2025 21:11 GMT/UTC)
A new game-based experiment by MIT researchers sheds light on the tradeoffs people are willing to make about data privacy.
A new paper co-authored by UBC Okanagan’s Dr. Julien Picault shows how scenes from hit shows like Narcos and Stranger Things can help students grasp complex economic concepts—from cartels and market control to creative destruction and inflation.
A new study suggests that populations of artificial intelligence (AI) agents, similar to ChatGPT, can spontaneously develop shared social conventions through interaction alone. The research from City St George’s, University of London and the IT University of Copenhagen suggests that when these large language model (LLM) artificial intelligence (AI) agents communicate in groups, they do not just follow scripts or repeat patterns, but self-organise, reaching consensus on linguistic norms much like human communities. The study has been published today in the journal, Science Advances.
Members of socially and economically marginalized groups in Montreal and Ottawa-Gatineau are at disproportionate risk in earthquakes, a new study has found.
Co-authored by McGill civil engineering professor Daniele Malomo, the study is the first in Canada to examine earthquake vulnerability through the lens of equity.
The researchers used spatial mapping and statistical techniques to identify where earthquake risk and social vulnerability intersect, revealing patterns of inequality tied to race, income, language and housing conditions. They drew their data from the 2021 Canadian Census and Canada’s Probabilistic Seismic Risk Model.
A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance Institution Kela reveals that the average duration of ADHD medication for children and adolescents is more than three years. However, reliable, controlled data on the safety of marketed ADHD medicines in children are available for only one year of follow-up.